Calpain inhibition attenuates right ventricular contractile dysfunction after acute pressure overload

Journal of Molecular and Cellular Cardiology

Volumn 44, Issue 1, 2008, Pages 59-68

  Greyson, Clifford R ^a   Schwartz, Gregory G ^a   Lu, Li ^a   Ye, Shuyu ^a   Helmke, Steve ^b   Xu, Ya ^a   Ahmad, Hasan ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Calpain; Calpastatin; Hypertension, Pulmonary; Myocardial contraction; Protease inhibitors; Ventricular dysfunction, Right

Indexed keywords

[1 [(1 FORMYL 2 PHENYLETHYL)CARBAMOYL] 2 METHYLPROPYL]CARBAMIC ACID BENZYL ESTER; CALPAIN; CALPASTATIN; DESMIN; PROTEINASE INHIBITOR; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SPECTRIN; TROPONIN I;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME INHIBITION; FEMALE; HEART RIGHT VENTRICLE; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE FUNCTION; HEART RIGHT VENTRICLE PRESSURE; HEART VENTRICLE CONTRACTILITY; HEART VENTRICLE PRESSURE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; STARLING LAW; SWINE;

ANIMALS; CALCIUM-BINDING PROTEINS; CALPAIN; DENSITOMETRY; DESMIN; DIPEPTIDES; FEMALE; HEMODYNAMICS; MALE; MYOCARDIAL CONTRACTION; PROTEIN PROCESSING, POST-TRANSLATIONAL; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; SPECTRIN; SWINE; TROPONIN; VENTRICULAR DYSFUNCTION, RIGHT; VENTRICULAR PRESSURE;

SUIDAE;

EID: 37549040627     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2007.10.010     Document Type: Article

References (46)

1. Hirsh J., and Hoak J. Management of deep vein thrombosis and pulmonary embolism. A statement for healthcare professionals. Council on Thrombosis (in consultation with the Council on Cardiovascular Radiology), American Heart Association. Circulation 93 12 (1996) 2212-2245
2. Goldhaber S.Z., Visani L., and De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 353 9162 (1999) 1386-1389
3. Goldhaber S.Z. Echocardiography in the management of pulmonary embolism. Ann Intern Med 136 9 (2002) 691-700
4. Stobierska-Dzierzek B., Awad H., and Michler R.E. The evolving management of acute right-sided heart failure in cardiac transplant recipients. J Am Coll Cardiol 38 4 (2001) 923-931
5. Dell'Italia L.J. The right ventricle: anatomy, physiology, and clinical importance. Curr Probl Cardiol 16 10 (1991) 653-720
6. Menzel T., Wagner S., Kramm T., Mohr-Kahaly S., Mayer E., Braeuninger S., et al. Pathophysiology of impaired right and left ventricular function in chronic embolic pulmonary hypertension: changes after pulmonary thromboendarterectomy. Chest 118 4 (2000) 897-903
7. D'Armini A.M., Cattadori B., Monterosso C., Klersy C., Emmi V., Piovella F., et al. Pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension: hemodynamic characteristics and changes. Eur J Cardiothorac Surg 18 6 (2000) 696-701 [discussion -2]
8. Greyson C., Xu Y., Cohen J., and Schwartz G.G. Right ventricular dysfunction persists following brief right ventricular pressure overload. Cardiovasc Res 34 2 (1997) 281-288
9. Greyson C., Xu Y., Lu L., and Schwartz G.G. Right ventricular pressure and dilation during pressure overload determine dysfunction after pressure overload. Am J Physiol Heart Circ Physiol 278 5 (2000) H1414-H1420
10. Kerbaul F., Rondelet B., Motte S., Fesler P., Hubloue I., Ewalenko P., et al. Effects of norepinephrine and dobutamine on pressure load-induced right ventricular failure. Crit Care Med 32 4 (Apr 2004) 1035-1040
11. Belcastro A.N., Shewchuk L.D., and Raj D.A. Exercise-induced muscle injury: a calpain hypothesis. Mol Cell Biochem 179 1-2 (1998) 135-145
12. Matsumura Y., Saeki E., Inoue M., Hori M., Kamada T., and Kusuoka H. Inhomogeneous disappearance of myofilament-related cytoskeletal proteins in stunned myocardium of guinea pig. Circ Res 79 3 (1996) 447-454
13. Urthaler F., Wolkowicz P.E., Digerness S.B., Harris K.D., and Walker A.A. MDL-28170, a membrane-permeant calpain inhibitor, attenuates stunning and PKC epsilon proteolysis in reperfused ferret hearts. Cardiovasc Res 35 1 (1997) 60-67
14. Yoshida K., Inui M., Harada K., Saido T.C., Sorimachi Y., Ishihara T., et al. Reperfusion of rat heart after brief ischemia induces proteolysis of calspectin (nonerythroid spectrin or fodrin) by calpain. Circ Res 77 3 (1995) 603-610
15. Spratt J.A., Tyson G.S., Glower D.D., Davis J.W., Muhlbaier L.H., Olsen C.O., et al. The end-systolic pressure-volume relationship in conscious dogs. Circulation 75 6 (1987) 1295-1309
16. Mehdi S. Cell-penetrating inhibitors of calpain. Trends Biochem Sci 16 4 (Apr 1991) 150-153
17. Glower D.D., Spratt J.A., Snow N.D., Kabas J.S., Davis J.W., Olsen C.O., et al. Linearity of the Frank-Starling relationship in the intact heart: the concept of preload recruitable stroke work. Circulation 71 5 (1985) 994-1009
18. Morris III J.J., Pellom G.L., Murphy C.E., Salter D.R., Goldstein J.P., and Wechsler A.S. Quantification of the contractile response to injury: assessment of the work-length relationship in the intact heart. Circulation 76 3 (1987) 717-727
19. Chow E., and Farrar D.J. Effects of left ventricular pressure reductions on right ventricular systolic performance. Am J Physiol 257 6 Pt 2 (1989) H1878-H1885
20. Karunanithi M.K., Michniewicz J., Copeland S.E., and Feneley M.P. Right ventricular preload recruitable stroke work, end-systolic pressure-volume, and dP/dtmax-end-diastolic volume relations compared as indexes of right ventricular contractile performance in conscious dogs. Circ Res 70 6 (1992) 1169-1179
21. Lu L., Xu Y., Zhu P., Greyson C., and Schwartz G.G. A common mechanism for concurrent changes of diastolic muscle length and systolic function in intact hearts. Am J Physiol Heart Circ Physiol 280 4 (2001) H1513-H1518
22. Barta J., Toth A., Edes I., Vaszily M., Papp J.G., Varro A., et al. Calpain-1-sensitive myofibrillar proteins of the human myocardium. Mol Cell Biochem 278 1-2 (Oct 2005) 1-8
23. Goll D.E., Thompson V.F., Li H., Wei W., and Cong J. The calpain system. Physiol Rev 83 3 (Jul 2003) 731-801
24. Wendt A., Thompson V.F., and Goll D.E. Interaction of calpastatin with calpain: a review. Biol Chem 385 6 (Jun 2004) 465-472
25. Newcomb J.K., Pike B.R., Zhao X., and Hayes R.L. Concurrent assessment of calpain and caspase-3 activity by means of western blots of protease-specific spectrin breakdown products. Methods Mol Biol 144 (2000) 219-223
26. Gao W.D., Atar D., Liu Y., Perez N.G., Murphy A.M., and Marban E. Role of troponin I proteolysis in the pathogenesis of stunned myocardium. Circ Res 80 3 (1997) 393-399
27. French J.P., Quindry J.C., Falk D.J., Staib J.L., Lee Y., Wang K.K., et al. Ischemia-reperfusion-induced calpain activation and SERCA2a degradation are attenuated by exercise training and calpain inhibition. Am J Physiol Lung Cell Mol Physiol 290 1 (Jan 2006) H128-H136
28. Papp Z., van der Velden J., and Stienen G.J. Calpain-I induced alterations in the cytoskeletal structure and impaired mechanical properties of single myocytes of rat heart [see comments]. Cardiovasc Res 45 4 (2000) 981-993
29. Muhlfeld C., Coulibaly M., Dorge H., Sellin C., Liakopoulos O., Ballat C., et al. Ultrastructure of right ventricular myocardium subjected to acute pressure load. Thorac Cardiovasc Surg 52 6 (Dec 2004) 328-333
30. Thomas S.A., Fallavollita J.A., Lee T.C., Feng J., and Canty Jr. J.M. Absence of troponin I degradation or altered sarcoplasmic reticulum uptake protein expression after reversible ischemia in swine [see comments]. Circ Res 85 5 (1999) 446-456
31. Foster D.B., and Van Eyk J.E. In search of the proteins that cause myocardial stunning [editorial; comment]. Circ Res 85 5 (1999) 470-472
32. Colantonio D.A., Van Eyk J.E., and Przyklenk K. Stunned peri-infarct canine myocardium is characterized by degradation of troponin T, not troponin I. Cardiovasc Res 63 2 (Aug 1 2004) 217-225
33. Lim C.C., Zuppinger C., Guo X., Kuster G.M., Helmes M., Eppenberger H.M., et al. Anthracyclines induce calpain-dependent titin proteolysis and necrosis in cardiomyocytes. J Biol Chem 279 9 (Feb 27 2004) 8290-8299
34. Lemler M.S., Bies R.D., Frid M.G., Sastravaha A., Zisman L.S., Bohlmeyer T., et al. Myocyte cytoskeletal disorganization and right heart failure in hypoxia-induced neonatal pulmonary hypertension. Am J Physiol Heart Circ Physiol 279 3 (2000) H1365-H1376
35. Murphy R.M., Verburg E., and Lamb G.D. Ca2+ activation of diffusible and bound pools of {micro}-calpain in rat skeletal muscle. J Physiol 576 Pt 2 (Oct 15 2006) 595-612
36. Bhatt A., Kaverina I., Otey C., and Huttenlocher A. Regulation of focal complex composition and disassembly by the calcium-dependent protease calpain. J Cell Sci 115 Pt 17 (Sep 1 2002) 3415-3425
37. Franchini K.G., Torsoni A.S., Soares P.H., and Saad M.J. Early activation of the multicomponent signaling complex associated with focal adhesion kinase induced by pressure overload in the rat heart [In Process Citation]. Circ Res 87 7 (2000) 558-565
38. Melloni E., Averna M., Stifanese R., De Tullio R., Defranchi E., Salamino F., et al. Association of calpastatin with inactive calpain: a novel mechanism to control the activation of the protease?. J Biol Chem 281 34 (Aug 25 2006) 24945-24954
39. Enns D., Karmazyn M., Mair J., Lercher A., Kountchev J., and Belcastro A. Calpain, calpastatin activities and ratios during myocardial ischemia-reperfusion. Mol Cell Biochem 241 1-2 (Dec 2002) 29-35
40. Sorimachi Y., Harada K., Saido T.C., Ono T., Kawashima S., and Yoshida K. Downregulation of calpastatin in rat heart after brief ischemia and reperfusion. J Biochem (Tokyo) 122 4 (Oct 1997) 743-748
41. Wei W., Fareed M.U., Evenson A., Menconi M.J., Yang H., Petkova V., et al. Sepsis stimulates calpain activity in skeletal muscle by decreasing calpastatin activity but does not activate caspase-3. Am J Physiol Regul Integr Comp Physiol 288 3 (Mar 2005) R580-R590
42. Shi Y., Melnikov V.Y., Schrier R.W., and Edelstein C.L. Downregulation of the calpain inhibitor protein calpastatin by caspases during renal ischemia-reperfusion. Am J Physiol Lung Cell Mol Physiol 279 3 (Sep 2000) F509-F517
43. Kawasaki H., Emori Y., and Suzuki K. Calpastatin has two distinct sites for interaction with calpain-effect of calpastatin fragments on the binding of calpain to membranes. Arch Biochem Biophys 305 2 (Sep 1993) 467-472
44. Chatterjee S., Gu Z.Q., Dunn D., Tao M., Josef K., Tripathy R., et al. d-Amino acid containing, high-affinity inhibitors of recombinant human calpain I. J Med Chem 41 15 (Jul 16 1998) 2663-2666
45. Tsuchida K., Aihara H., Isogai K., Hanada K., and Shibata N. Degradation of myocardial structural proteins in myocardial infarcted dogs is reduced by Ep459, a cysteine proteinase inhibitor. Biol Chem Hoppe Seyler 367 1 (Jan 1986) 39-45
46. Barnoy S., Glaser T., and Kosower N.S. Calpain and calpastatin in myoblast differentiation and fusion: effects of inhibitors. Biochim Biophys Acta 1358 2 (Sep 11 1997) 181-188